HomeInsightsStock Comparison

Orchid Pharma Ltd vs Pfizer Ltd Stock Comparison

Orchid Pharma Ltd vs Pfizer Ltd Stock Comparison

Last Updated on: Sep 17, 2025

Key Highlights

  • The Latest Trading Price of Orchid Pharma Ltd is ₹ 711.95 as of 17 Sep 10:37.
  • The P/E Ratio of Orchid Pharma Ltd changed from 33.9 on March 2023 to 39.5 on March 2025 . This represents a CAGR of 5.23% over 3 yearsThe P/E Ratio of Pfizer Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Orchid Pharma Ltd changed from ₹ 10061 crore on March 2021 to ₹ 3940 crore on March 2025 . This represents a CAGR of -17.10% over 5 yearsThe Market Cap of Pfizer Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Orchid Pharma Ltd for the Jun '25 is ₹ 184.38 crore as compare to the Mar '25 revenue of ₹ 241.38 crore. This represent the decline of -23.61% The revenue of Pfizer Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Orchid Pharma Ltd for the Jun '25 is ₹ 25.62 crore as compare to the Mar '25 ebitda of ₹ 31.88 crore. This represent the decline of -19.64% The ebitda of Pfizer Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Orchid Pharma Ltd changed from ₹ 10.78 crore to ₹ 13.71 crore over 9 quarters. This represents a CAGR of 11.28% The net profit of Pfizer Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Orchid Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Pfizer Ltd changed from 296.54 % on March 2020 to 98.34 % on March 2025 . This represents a CAGR of -16.80% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Orchid Pharma Ltd

  • Orchid Pharma Limited, is one of the leading pharmaceutical companies in India head quartered in Chennai and involved in development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals with exports spanning over 40 countries.
  • Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India.
  • The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai. The Company has a portfolio of antibiotics, and veterinary products.
  • Antibiotics are life-saving drugs used to ght infections.
  • Different classes of antibiotics include Beta-lactam, Macrolide, Fluoroquinolone, Imidazoleetc.

About Pfizer Ltd

  • Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
  • The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories.
  • It has its own manufacturing facility at Goa and Thane.
  • It has the distinction of being the first pharmaceutical company in India to start clinical research.
  • The Company sells products in nearly 185 countries having 43 manufacturing sites globally.

Orchid Pharma Ltd News Hub

News

Orchid Pharma schedules AGM

Orchid Pharma announced that the Annual General Meeting(AGM) of the company will be held o...

Read more

19 Aug 2025 17:40

News

Orchid Pharma announces board meeting date

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 20...

Read more

06 Aug 2025 15:11

News

Orchid Pharma gets formal nod from Court of France for Allecra Therapeutics acquisition

On 30 July 2025, the company had announced the signing of an agreement with the Insolvency...

Read more

06 Aug 2025 10:01

News

Orchid Pharma schedules EGM

Orchid Pharma announced that an Extra Ordinary General Meeting (EGM) of the Company will b...

Read more

04 Jun 2025 14:03

News

Orchid Pharma to table results

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 26 May 2025....

Read more

21 May 2025 18:17

News

Orchid Pharma continues to be under rating watch with developing implications

Orchid Pharma announced that CARE has continued the rating CARE A-/ CARE A2 while maintain...

Read more

07 Mar 2025 13:33

Pfizer Ltd News Hub

News

Pfizer jumps after robust Q1 earnings

On a standalone basis, net profit rose 27.23% year-on-year to Rs 191.75 crore in Q1 FY26 f...

Read more

14 Aug 2025 10:09

News

Volumes soar at Pfizer Ltd counter

Muthoot Finance Ltd, Brigade Enterprises Ltd, Authum Investment & Infrastructure Ltd, Astr...

Read more

14 Aug 2025 14:30

News

Pfizer to discuss results

Pfizer will hold a meeting of the Board of Directors of the Company on 13 August 2025. Pow...

Read more

08 Aug 2025 16:58

News

Pfizer Ltd Spurts 6.26%

Pfizer Ltd rose 6.26% today to trade at Rs 5689.95. The BSE Healthcare index is up 0.15% t...

Read more

28 Jul 2025 09:30

News

Pfizer to hold AGM

Pfizer announced that the 74th Annual General Meeting(AGM) of the company will be held on ...

Read more

21 May 2025 11:43

News

Board of Pfizer recommends final dividend

Pfizer announced that the Board of Directors of the Company at its meeting held on 19 May ...

Read more

20 May 2025 12:47

SWOT Analysis Of Pfizer Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Orchid Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Pfizer Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Orchid Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Orchid Pharma Ltd and Pfizer Ltd

Which company has a larger market capitalization, Orchid Pharma Ltd or Pfizer Ltd?

Market cap of Orchid Pharma Ltd is 3,595 Cr while Market cap of Pfizer Ltd is 23,508 Cr

What are the key factors driving the stock performance of Orchid Pharma Ltd and Pfizer Ltd?

The stock performance of Orchid Pharma Ltd and Pfizer Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Orchid Pharma Ltd and Pfizer Ltd?

As of September 17, 2025, the Orchid Pharma Ltd stock price is INR ₹708.9. On the other hand, Pfizer Ltd stock price is INR ₹5138.65.

How do dividend payouts of Orchid Pharma Ltd and Pfizer Ltd compare?

To compare the dividend payouts of Orchid Pharma Ltd and Pfizer Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions